TBDC is a joint effort between the Lone Star BDF and Texas Central Texas Central Bleeding Disorders, bringing over 800 people from all over the state of Texas together for a weekend of education, networking, and fun. Educational sessions are available for every step of life with a bleeding disorder. A fun Final Night event wraps up the weekend, with activities for the whole family. To register online for the 2023 Conference at The Woodlands Waterway Marriott, June 16-18, please click here.
SAN RAFAEL, Calif., March 6, 2023 — BioMarin Pharmaceutical Inc., a global biotechnology company dedicated to transforming lives through genetic discovery, announced that it received notice this afternoon from the U.S. Food and Drug Administration (FDA) that the agency has extended review of the company’s Biologics License Application (BLA) for ROCTAVIAN™ (valoctocogene roxaparvovec) gene therapy for adults
The post BioMarin Update: FDA Extends PDUFA Target Action Date to June 30, 2023 appeared first on Hemophilia Federation of America.
The long-heralded Medicaid “unwinding” has begun. As previously reported, state Medicaid programs have, since the start of the COVID-19 pandemic, operated under a law that prohibited them from disenrolling Medicaid enrollees for the duration of the public health emergency (PHE). Congress changed that requirement in December 2022, delinking the Medicaid continuous enrollment obligation from the PHE.
The post The Complexity of Unwinding Medicaid appeared first on Hemophilia Federation of America.
Source: Sanofi Press Release Sanofi announces that the U.S. Food and Drug Administration approved ALTUVIIIO™ [Antihemophilic Factor (Recombinant), Fc-vWF-XTEN Fusion Protein-ehtl], previously known as efanesoctocog alfa, a first-in-class, high-sustained factor VIII replacement therapy for adults and children with hemophilia A. Sanofi states that with ALTUVIIIO, they are looking to raise the bar for people with
The post FDA Approves Sanofi’s Once-Weekly ALTUVIIIO™ appeared first on Hemophilia Federation of America.
Dear Addy, I recently attended an event and learned about submitting issues with my insurance to HFA’s Project CALLS. I have an insurance issue, however, I still have some questions about how CALLS works and what happens when I submit an issue. Can you explain the process? Signed, CALLS Quandary Dear Quandary, You are not
The post Dear Addy: Project CALLS appeared first on Hemophilia Federation of America.
This Black History Month, HFA asks our community to think back on the family members they’ve loved and the moments they created. We ask our community to think on the diversity of our community, the stories we’ve shared, and the people of color who helped make the bleeding disorder community as strong as it is
The post Finding Strength Through Diversity appeared first on Hemophilia Federation of America.
